Aventis Daptacel May Alleviate DTaP Shortage; Approval Expected Shortly

Aventis Pasteur expects the approval of Daptacel to enable the company to resume filling CDC contracts for diphtheria, tetanus and acellular pertussis vaccine

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet